Description
A cholinesterase inhibitor (IC50s = 0.35 and 1.0 μM for human AChE and BChE, respectively); protects bovine red blood cells from toxic and irreversible AChE inhibition by organophosphates; binds to AChE to prevent irreversible inhibition and reduce muscle depolarization induced by soman ex vivo in human diaphragm muscle fibers; prevents tachycardia, increases parasympathetic, and decreases sympathetic tone in mice following myocardial infarction (3 mg/kg per day for four weeks)
Formal name: 3-[[(dimethylamino)carbonyl]oxy]-1-methyl-pyridinium, monobromide
Synonyms: NSC 679759|Ro 1-5130
Molecular weight: 261.1
CAS: 101-26-8
Purity: ≥98%
Formulation: A solid
Product Type|Biochemicals|Small Molecule Inhibitors|Acetylcholine Turnover||Research Area|Cardiovascular System|Blood||Research Area|Cardiovascular System|Cardiovascular Diseases|Myocardial Infarction||Research Area|Neuroscience||Research Area|Toxicology|Environmental